DRW Securities, LLC Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$950.5B
Holdings
446
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (446 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 401 | ABGAMERISOURCEBERGEN CORP | 2,256 | $207.0M | 0.02% | |
| 402 | EXPEEXPEDIA INC DEL | 1,728 | $207.0M | 0.02% | |
| 403 | HSTHOST HOTELS & RESORTS INC | 10,368 | $206.0M | 0.02% | |
| 404 | MSIMOTOROLA SOLUTIONS INC | 2,280 | $206.0M | 0.02% | |
| 405 | ETRENTERGY CORP NEW | 2,520 | $205.0M | 0.02% | |
| 406 | —GGP INC | 8,760 | $205.0M | 0.02% | |
| 407 | BLMNBLOOMIN BRANDS INC | 9,500 | $203.0M | 0.02% | Call |
| 408 | BTUSDBT GROUP PLC | 11,129 | $203.0M | 0.02% | |
| 409 | MRO*MARATHON OIL CORP | 11,904 | $202.0M | 0.02% | |
| 410 | URIUNITED RENTALS INC | 1,176 | $202.0M | 0.02% | |
| 411 | AEEAMEREN CORP | 3,408 | $201.0M | 0.02% | |
| 412 | —SUCAMPO PHARMACEUTICALS INC | 10,900 | $196.0M | 0.02% | Call |
| 413 | FDDFIRST TR STOXX EURO DIV FD COMMON | 14,137 | $194.0M | 0.02% | |
| 414 | ARRYEURARRAY BIOPHARMA INC | 15,000 | $192.0M | 0.02% | |
| 415 | PIRSPIERIS PHARMACEUTICALS INC | 23,000 | $174.0M | 0.02% | |
| 416 | GYRECATALYST BIOSCIENCES INC | 12,000 | $164.0M | 0.02% | |
| 417 | IMGNEURIMMUNOGEN INC | 24,000 | $154.0M | 0.02% | |
| 418 | —OBSEVA SA | 15,610 | $152.0M | 0.02% | |
| 419 | —ARQULE INC | 90,000 | $149.0M | 0.02% | |
| 420 | —SIERRA ONCOLOGY INC | 40,000 | $149.0M | 0.02% | |
| 421 | CTIC1USDCTI BIOPHARMA CORP | 51,561 | $138.0M | 0.01% | |
| 422 | KALVKALVISTA PHARMACEUTICALS INC | 12,000 | $117.0M | 0.01% | |
| 423 | —CREDIT SUISSE NASSAU BRH | 20,411 | $113.0M | 0.01% | |
| 424 | CBAYUSDCYMABAY THERAPEUTICS INC | 12,000 | $110.0M | 0.01% | |
| 425 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 30,000 | $105.0M | 0.01% | |
| 426 | —REGULUS THERAPEUTICS INC | 100,000 | $104.0M | 0.01% | |
| 427 | ICADUSDICAD INC | 27,285 | $94.0M | 0.01% | |
| 428 | —APTOSE BIOSCIENCES INC | 40,000 | $90.0M | 0.01% | |
| 429 | XENEXENON PHARMACEUTICALS INC | 30,000 | $85.0M | 0.01% | |
| 430 | OTICEUROTONOMY INC | 15,000 | $83.0M | 0.01% | |
| 431 | ALDXALDEYRA THERAPEUTICS INC | 12,000 | $82.0M | 0.01% | |
| 432 | —CONTRAFECT CORP | 80,000 | $81.0M | 0.01% | |
| 433 | —ADURO BIOTECH INC | 10,000 | $75.0M | 0.01% | |
| 434 | —STEADYMED LTD | 20,000 | $74.0M | 0.01% | |
| 435 | —PROTEON THERAPEUTICS INC | 38,686 | $74.0M | 0.01% | |
| 436 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 12,885 | $70.0M | 0.01% | |
| 437 | —TONIX PHARMACEUTICALS HLDG C | 20,000 | $69.0M | 0.01% | |
| 438 | —IMMUNE DESIGN CORP | 17,000 | $66.0M | 0.01% | |
| 439 | —ONCOMED PHARMACEUTICALS INC | 13,740 | $56.0M | 0.01% | |
| 440 | —NOVUS THERAPEUTICS INC | 12,489 | $51.0M | 0.01% | |
| 441 | CHKEURCHESAPEAKE ENERGY CORP | 12,744 | $50.0M | 0.01% | |
| 442 | —CASCADIAN THERAPEUTICS INC | 13,000 | $48.0M | 0.01% | |
| 443 | —ZAFGEN INC | 10,000 | $46.0M | 0.00% | |
| 444 | —LIPOCINE INC NEW | 12,000 | $41.0M | 0.00% | |
| 445 | —CURIS INC | 50,000 | $35.0M | 0.00% | |
| 446 | GONGERON CORP | 10,000 | $18.0M | 0.00% |
PreviousPage 5 of 5